These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9486582)

  • 1. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
    Vikram B; Chadha M; Malamud SC; Hecht H; Grabstald H
    Cancer; 1998 Mar; 82(5):918-22. PubMed ID: 9486582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current status of adjuvant chemotherapy of invasive bladder cancer].
    Ozono S; Sasaki K; Watanabe S; Maruyama Y; Ohara S; Babaya K; Yamada K; Hirao Y; Okajima E
    Hinyokika Kiyo; 1991 Dec; 37(12):1589-95. PubMed ID: 1785379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neoadjuvant chemotherapy (M-VAC) in invasive cancer of the bladder. Our experience].
    González Enguita C; Caro Cebrián C; Roncalés Badal A; Gil Sanz MJ; Martínez Bengoechea J; Rioja Sanz LA
    Arch Esp Urol; 1990; 43 Suppl 2():197-204. PubMed ID: 2096779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polychemotherapy in advanced bladder cancer. Practicality and clinical results].
    Klän R; Knispel H; Huland H
    Urologe A; 1992 Jul; 31(4):247-50. PubMed ID: 1514213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neoadjuvant chemotherapy (M-VAC) for locally invasive bladder cancer].
    Kamoto T; Kawakita M; Okabe T; Matsumoto M; Matsuda T; Yoshida O
    Hinyokika Kiyo; 1992 Apr; 38(4):405-11. PubMed ID: 1529813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder-sparing approach in the treatment of invasive bladder cancer.
    Wajsman Z; Marino R; Parsons J; Oblon D; McCarley D
    Semin Urol; 1990 Aug; 8(3):210-5. PubMed ID: 2119051
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase I-II pilot study on the efficacy and tolerability of neoadjuvant chemotherapy (Rescue M-VEC) and preoperative radiation therapy for infiltrating bladder cancer: results of an 18-month follow-up.
    Voce S; Montanari F; Arnone S; Dal Pozzo C; Suprani G; Cerullo G; Fornarola V
    Arch Esp Urol; 1992 Jun; 45(5):491-8. PubMed ID: 1510485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of invasive bladder cancer].
    Kotake T
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2375-82. PubMed ID: 1952956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neoadjuvant chemotherapy with MVC (methotrexate, vinblastine, cisplatin)in the treatment of infiltrating transitional carcinoma of the bladder].
    Campo B; Torelli T; Leidi GL; Corrada P; Bacchioni AM; Ordesi G; Zanitzer L
    Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):237-42. PubMed ID: 2142807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative and postoperative adjuvant chemotherapy using CISCA (cyclophosphamide, doxorubicin, and cisplatin) in the treatment of invasive transitional-cell carcinoma of the bladder.
    Lynch DF
    Urol Clin North Am; 1991 Aug; 18(3):543-6. PubMed ID: 1877118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Postoperative adjuvant M-VAC chemotherapy for invasive bladder cancer].
    Yamashita S; Taniguchi K; Morimitsu H; Suzu H; Kanetake H; Saito Y; Yushita Y; Sakuragi T
    Hinyokika Kiyo; 1992 May; 38(5):519-24. PubMed ID: 1609658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiotherapy in the interdisciplinary approach to the treatment of bladder carcinoma].
    Dunst J
    Strahlenther Onkol; 1991 Oct; 167(10):563-80. PubMed ID: 1948642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Organ-preserving therapy in invasive bladder carcinoma].
    Dunst J; Bornhof C; Altendorf-Hofmann A; Wittekind C; Schrott KM; Sauer R
    Dtsch Med Wochenschr; 1992 Nov; 117(47):1783-8. PubMed ID: 1425303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transurethral resection in regionally advanced bladder cancer.
    Herr HW
    Urol Clin North Am; 1992 Nov; 19(4):695-700. PubMed ID: 1441026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neoadjuvant chemotherapy of infiltrating carcinoma of the bladder: our experience].
    Graziotti P; Personeni A; Benzone S; Giannone C; Giardina G; Guizzetti C; Ranieri A; Romano C; Taino R; Lembo A
    Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):223-9. PubMed ID: 2142805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the combined M-VAC therapy in invasive bladder cancer].
    Asano K; Masuda F; Suzuki H; Takamizawa S; Kaneko R
    Hinyokika Kiyo; 1991 Dec; 37(12):1645-50. PubMed ID: 1785388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraarterial COMPA (cis-diammine-dichloroplatinum (II), vincristine, methotrexate, peplomycin, adriamycin) chemotherapy for bladder cancer].
    Tsujino S; Ito T; Aizawa T; Namiki K; Ohno Y; Yamamoto S; Ishibashi K; Miki M; Yamauchi T; Kawai T
    Hinyokika Kiyo; 1992 Oct; 38(10):1101-7. PubMed ID: 1282770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ conservation in deeply invasive bladder cancer.
    Fair WR
    Prog Clin Biol Res; 1991; 370():119-26. PubMed ID: 1924440
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy in deeply invasive bladder cancer: the Italian experience. The Lombard Urologists.
    Semin Urol; 1990 Aug; 8(3):205-9. PubMed ID: 2204982
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.
    Higano CS; Tangen CM; Sakr WA; Faulkner J; Rivkin SE; Meyers FJ; Hussain M; Baker LH; Russell KJ; Crawford ED;
    Cancer; 2008 May; 112(10):2181-7. PubMed ID: 18404692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.